Hemispherx BioPharma (HEB)

[newpenny]

Here is a link to the full article. My thoughts are that until HEB finishes with some type of preliminary tests and has proof that one of its drugs will benefit Ebola patients, the price of the stock will stay about where it is. The only positive that I can see is that if HEB does have something that works, they will be able to produce it much faster as the other companies had small supplies of the drugs but they have been used up treating a few patients. Hopefully, the trials will happen quickly and the results will be positive. JMO

http://fortune.com/2014/10/02/as-ebola-spreads-drug-companies-race-to-develop-treatments/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+fortunebrainstormtech+%28Fortune+Brainstorm+Tech%29


Hemispherx Biopharma

Hemispherx Biopharma HEB -4.87% will begin testing two of its existing drugs in partnership with the DoD to see if the drugs can combat the deadly disease. Alferon, one of the drugs, is currently used to treat genital warts caused by the human papilloma virus. The other medicine, Ampligen, is an experimental antiviral used to combat a range of disorders.